Chrissy Metz says GLP-1 helped her health after years of skepticism
NEWYou can now listen to Fox News articles! Chrissy Metz is opening up about her decision to use…
GLP-1s not a ‘lifestyle product’ – The Star
GLP-1s not a ‘lifestyle product’ The StarCalls to poison centers skyrocket amid rise in use of GLP-1 drugs, experts…
Once-weekly workout burns nearly as much fat as 3 workouts a week
One and done. The CDC and other health agencies recommend adults aim for at least 150 minutes of…
Daily tomatoes lowered a key marker of liver fat in MASLD trial
A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Loving your body in a world where weight stigma helps sell GLP-1 drugs
Whether you’re living in a body that’s large or small, the rise of GLP-1 advertising and its use…
Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
From 98 Kg To 78 Kg: Woman Shares The Diet Plan That Helped Her Lose 20 Kg
There is a fine line between body shaming and expressing concern about someone’s obesity. Adity Bhargav’s story highlights…
An enzyme might help fight against your body’s aging
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business Outlook
Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…